Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 24, 08:18 AM 2012  
RJF SF KCG GHL ITG AI 
 
 
  NYSE  7,541  



Processing
Collecting data for ^NYA and HSP ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 NYSE  and   Hospira Inc.
Check Correlation Matrix  
Daily Returns (%)
NYA  HSP  
Timeline
Given investment horizon of 30 days, NYSE is expected to generate 0.59 times more return on investment than Hospira. However, NYSE is 1.69 times less risky than Hospira. It trades about -0.32 of its potential returns per unit of risk. Hospira Inc. is currently generating about -0.26 per unit of risk. If you would invest 807,079 in NYSE on April 24, 2012 and sell it today you would lose (52,989) from holding NYSE or give up 6.57% of portfolio value over 30 days.

Diversification

Poor diversification
Overlapping area represents amount of risk that can be diversified away by holding NYSE and Hospira Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.7
 Parameters
Time Period1 Month [change]
DirectionPositive HSP Moved Up vs ^NYA
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between NYA and HSP with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between NYA and HSP to your reader
 
Get social with Correlation between NYA and HSP
 Share Correlation between NYA and HSP 
Share Share Correlation between NYA and HSP
    
    
 
       
Predicted Return Density
Expected Daily Returns   
NYA  HSP  

NYSE

 
    
    
NYSE
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days NYSE has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
CENTRICA vs. NYSE
Berkshire Bancorp Inc. vs. NYSE
SAP vs. NYSE
LINDE vs. NYSE
Spark Infrastructure Group vs. NYSE
SAFRAN vs. NYSE
KABEL DEUT HLDG vs. NYSE
Curis Inc. vs. NYSE
Park Bancorp Inc. vs. NYSE
ASML Holding NV vs. NYSE
STANDARD LIFE vs. NYSE
  

Hospira Inc.

 
    
    
Hospira
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Hospira Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Hospira Inc.
Elan Corporation plc vs. Hospira Inc.
Alkermes Inc. vs. Hospira Inc.
PetMed Express Inc. vs. Hospira Inc.
Acura Pharmaceuticals Inc. vs. Hospira Inc.
Delcath Systems Inc. vs. Hospira Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting